Skip to content

Poly-Flex Pacing Leads

by Intermedics, Inc. 510(k)

Active United States

510(k) K813028

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK813028 Date10 Dec 1981ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Poly-Flex Pacing Leads are classified as Permanent Pacemaker Electrodes, designed for use in cardiac pacing systems. These leads are implanted within the heart to deliver electrical impulses that regulate abnormal heart rhythms, ensuring proper cardiac function in patients with bradycardia or other conduction disorders.

These leads are intended for single-use implantation and are regulated under FDA 510(k) clearance (K813028) as a Class 3 medical device. They are supplied sterile and comply with regulation 870.3680, intended for use in cardiovascular procedures. The device is manufactured by Intermedics, Inc., and includes multiple model references as listed in the FDA database.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are the Poly-Flex Pacing Leads designed for reuse or are they intended for single-use only?

    The Poly-Flex Pacing Leads are explicitly designed for single-use implantation only. This is clearly stated in the device description, ensuring they are used once and then discarded to maintain sterility and patient safety.

  • What types of heart conditions are these leads intended to address, and how do they work?

    These leads are intended for patients with bradycardia or conduction disorders, delivering regulated electrical impulses to the heart to maintain proper rhythm. They are implanted within the heart as part of a cardiac pacing system, ensuring consistent pacing when the heart’s natural conduction system is impaired.

  • How are the Poly-Flex Pacing Leads supplied, and are they sterile upon receipt?

    The leads are supplied sterile and ready for immediate use, as specified in the device description. This ensures they meet regulatory standards for cardiovascular procedures without requiring additional sterilization before implantation.

  • What regulatory pathway was followed for FDA clearance of these leads, and which advisory committee reviewed them?

    The Poly-Flex Pacing Leads received FDA 510(k) clearance (K813028) under the Traditional pathway, with a decision of *Substantially Equivalent* (SESE). The review was conducted by the Cardiovascular (CV) Advisory Committee, reflecting their classification as a Class 3 medical device under regulation 870.3680.

  • How many model references are associated with the Poly-Flex Pacing Leads, and what does this indicate about their availability?

    The device includes multiple model references (listed in the FDA database, e.g., 3002618605, 1028232, etc.), suggesting a range of configurations or sizes to accommodate different patient anatomies or clinical needs. This variety ensures compatibility with various cardiac pacing systems and implantation scenarios.